Optonol

Acquired

Miniature glaucoma implants for surgical precision

Optonol was founded in 1996, is headquartered in Neve Ilan, Israel, lists 11–50 employees, and has 1 recorded funding round.

Headquarters
Neve Ilan
Employees
11–50
Founded
1996
Business Model
B2B
Last Round
Series CFeb 2009
Rounds
1
Acquired by
Alcon Inc.Dec 2009

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Optonol Ltd. was founded in 1996 as a spin-off of Jerusalem-based stent developer Medinol Ltd. The company developed the Ex-PRESS miniature glaucoma implant — a device smaller than a grain of rice made from surgical stainless steel with an internal diameter of 50 or 200 microns. The Ex-PRESS shunt is used in filtering surgery to lower intraocular pressure in glaucoma patients, offering a less invasive alternative to traditional trabeculectomy. Optonol's development center was located in Neve Ilan near Jerusalem, Israel. The company raised over $20 million from investors including Israel Healthcare Ventures and Pitango Venture Capital before being acquired by Alcon in 2010 for an initial payment of $150 million with additional milestone payments.

Summary

Optonol is a Healthcare company based in Neve Ilan, Israel, founded in 1996. It lists 11–50 employees. Its most recent funding was a Series C round in Feb 2009. Investors include Israel Healthcare Ventures and Pitango Growth.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionDec 2009

Sign up to see all 2 events

Funding: Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Optonol on Indexed.vc
<a href="https://indexed.vc/companies/optonol"><img src="https://indexed.vc/api/badge/company/optonol" alt="Optonol on Indexed.vc" width="260" height="76" /></a>